Design Therapeutics, Inc. (DSGN)
NASDAQ · Healthcare
Design Therapeutics, Inc. Operating Income 2020–2025
Design Therapeutics, Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Design Therapeutics, Inc. operating income for the quarter ending March 31, 2026 was -19.7 M, a 3.49% decrease year-over-year.
- Design Therapeutics, Inc. operating income for the twelve months ending March 31, 2026 was -44.0 M.
- Design Therapeutics, Inc. annual operating income for 2025 was -79.5 M, a 27.39% increase from 2024.
- Design Therapeutics, Inc. annual operating income for 2024 was -62.4 M, a 648.90% increase from 2020.
- Design Therapeutics, Inc. annual operating income for 2020 was -8.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Design Therapeutics, Inc. Operating Income — FAQ
Design Therapeutics, Inc. (DSGN) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Design Therapeutics, Inc.'s operating income?
Design Therapeutics, Inc. (DSGN) reported operating income of -$79M for fiscal 2025.
Where can I see DSGN's operating income history?
The chart and table above show Design Therapeutics, Inc.'s operating income by year and by quarter, including the growth rate.